Dermata Therapeutics, Inc. (DRMAW)
NCM
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Peers in industry
Dermata Therapeutics, Inc. has no peer companies in this window.
Recent press releases
April 2026
Dermata Therapeutics, Inc. — PRE 14A Filing
# 🧾 What This Document Is This is a **PRELIMINARY PROXY STATEMENT** (a "pre-proxy"). Think of it as a detailed "meeting agenda" and "voter guide" that Dermata Therapeutics is sending to its shareholders before their annual meeting. It’s preliminary, meaning the final details might be tweaked. Its j
SEC filings
All filings →Insider trades
All insider trades →Dermata Therapeutics, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Dermata Therapeutics, Inc.
All people →No officers or directors have been indexed for Dermata Therapeutics, Inc..